The EU’s medicines watchdog on Thursday approved Valneva’s anti-Covid jab, the sixth coronavirus vaccine for use within the 27-nation bloc.
“EMA has recommended granting a marketing authorisation for Covid-19 vaccine Valneva for use in the primary vaccination of people from 18 to 50 years of age,” the Amsterdam-based agency said in a statement.